China Resources Pharmaceutical Group Limited (HKG: 3320)

China Resources Pharmaceutical Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	22,292	24,651	15,224	17,513	11,231	12,524
Short-Term Investments	10,787	7,581	7,507	11,988	6,914	5,114
Trading Asset Securities	-	-	-	-	-	532.59
Cash & Short-Term Investments	33,079	32,231	22,731	29,501	18,146	18,170
Cash Growth	16.84%	41.79%	-22.95%	62.58%	-0.13%	-59.31%
Accounts Receivable	107,525	95,695	84,818	95,958	86,787	75,136
Other Receivables	6,980	6,912	6,845	9,344	7,359	9,023
Receivables	114,504	102,607	91,663	105,302	94,146	84,159
Inventory	36,996	31,875	26,547	29,688	24,585	22,332
Prepaid Expenses	7,286	4,797	4,953	4,304	3,740	3,666
Restricted Cash	-	-	-	12.75	-	24.13
Other Current Assets	5,744	7,057	6,366	7,802	6,492	4,590
Total Current Assets	197,609	178,568	152,259	176,610	147,109	132,943
Property, Plant & Equipment	24,784	25,043	21,698	25,038	22,642	21,830
Long-Term Investments	6,873	6,878	6,622	7,841	6,334	5,244
Goodwill	21,454	21,454	20,409	24,902	21,072	19,306
Other Intangible Assets	7,879	6,536	6,359	7,548	5,762	4,960
Long-Term Deferred Tax Assets	1,838	1,773	1,435	1,310	969.85	856.09
Long-Term Deferred Charges	-	1,481	1,206	1,453	1,178	1,090
Other Long-Term Assets	5,922	5,037	5,546	3,862	3,437	3,416
Total Assets	266,359	246,770	215,534	248,562	209,372	190,025
Accounts Payable	58,729	54,451	48,853	52,380	45,697	42,747
Accrued Expenses	3,700	4,231	5,360	5,187	4,049	3,631
Short-Term Debt	-	-	10,167	12,297	11,196	15,025
Current Portion of Long-Term Debt	54,010	45,760	35,941	46,962	40,127	27,866
Current Portion of Leases	456.67	463.53	495.95	583.81	709.96	614.39
Current Income Taxes Payable	876.5	730.03	667.3	894.39	671.13	452.96
Current Unearned Revenue	4,805	4,023	3,538	3,557	2,478	1,652
Other Current Liabilities	21,415	24,574	16,747	19,461	17,691	14,683
Total Current Liabilities	143,992	134,233	121,770	141,323	122,620	106,672
Long-Term Debt	20,858	15,092	9,042	7,181	2,008	9,243
Long-Term Leases	843.74	844.89	770.27	931.86	1,156	1,633
Long-Term Unearned Revenue	-	788.58	775.14	890.78	651.44	601.13
Long-Term Deferred Tax Liabilities	1,678	1,718	1,587	1,965	1,669	1,507
Other Long-Term Liabilities	1,132	356.96	203.29	197.83	206.37	220.44
Total Liabilities	169,241	153,795	134,977	153,578	129,342	120,443
Common Stock	24,630	24,630	24,630	27,241	27,241	27,241
Retained Earnings	31,342	29,705	26,731	28,397	25,382	22,785
Comprehensive Income & Other	-7,607	-8,376	-7,804	-4,657	-6,153	-9,315
Total Common Equity	48,366	45,960	43,557	50,981	46,470	40,711
Minority Interest	48,752	47,015	37,000	44,003	33,560	28,870
Shareholders' Equity	97,118	92,975	80,557	94,984	80,029	69,582
Total Liabilities & Equity	266,359	246,770	215,534	248,562	209,372	190,025
Total Debt	76,168	62,161	56,416	67,956	55,197	54,382
Net Cash (Debt)	-43,089	-29,930	-33,685	-38,455	-37,051	-36,211
Net Cash Per Share	-6.86	-4.76	-5.36	-6.12	-5.90	-5.76
Filing Date Shares Outstanding	6,283	6,283	6,283	6,283	6,283	6,285
Total Common Shares Outstanding	6,283	6,283	6,283	6,283	6,283	6,285
Working Capital	53,617	44,335	30,489	35,287	24,489	26,271
Book Value Per Share	7.70	7.32	6.93	8.11	7.40	6.48
Tangible Book Value	19,033	17,969	16,789	18,532	19,636	16,445
Tangible Book Value Per Share	3.03	2.86	2.67	2.95	3.13	2.62
Buildings	-	16,124	13,507	15,946	14,334	13,118
Machinery	-	12,511	10,556	11,496	9,920	8,630
Construction In Progress	-	1,339	1,930	1,193	633.67	856.18
Leasehold Improvements	-	960.31	741.77	810.38	697.55	538.41

Source: S&P Capital IQ. Standard template. Financial Sources.